Remove Clinical Trials Remove Concentrates Remove Document
article thumbnail

FSD Pharma Inc. Announces Termination of FSD-201 Phase 2 Clinical Trial

Cannabis Law Report

Nasdaq:HUGE) (CSE:HUGE) (FRA:0K9) (the “ Company ” or “ FSD ”) announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide (“PEA”), or FSD-201, for use in treating COVID-19. TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. Anthony Durkacz. 1-844-978-3540.

article thumbnail

CBG ‘very helpful’ when treating medical conditions, first survey of its kind finds

The Cannigma

When asked what concentration of CBG appears to be most effective, Dr. Ethan Russo, one of the authors of the study, told The Cannigma “I would not put it in terms of concentration. No clinical trial was used in the compilation of the study. Rather, doses of CBG of 5 mg or above orally seem to exert noticeable effects.”.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Can Marijuana Reverse Bone Loss?

CannaMD

The cannabinoid receptor known as CB1 , which occurs in heavy concentration in the brain, was identified as playing a role in pathophysiological events ranging from memory deficits to neurodegenerative disorders. In their summary, the study’s authors noted that. CBD alone is sufficiently effective in enhancing fracture healing.

Marijuana 111
article thumbnail

Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers

Cannabis Law Report

Borrowing from what is already known about safe circulating levels in patients for generic cepharanthine, the Company’s current 60 cancer screen was designed to investigate the impact of their patented cepharanthine formulation at concentrations that are predicted to be safe to patients 1. ” Next Steps. dcohen@pharmadrug.co.

article thumbnail

How Medical Marijuana Helps With Multiple Sclerosis Symptoms

MMJ Recs

Cognitive changes, such as difficulties with memory and concentration, as well as emotional challenges like depression and anxiety, can also occur. Some clinical trials have shown that cannabinoids, particularly THC and CBD, effectively reduce muscle spasticity and pain in MS patients.

Marijuana 111
article thumbnail

Here’s what you need to know about cannabis research

The Cannigma

Observational studies involve watching the subject and documenting outcomes like a reporter, whereas in interventional studies the researchers take a specific action and monitor the response. This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible.

article thumbnail

Study: CBD “Promising” Therapy for Cocaine Addiction

CannaMD

Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., After the full-text analyses, 14 were selected for the present review. Most studies were published in the last five years, while the rest were published between 1994 and 2008.

Therapy 98